Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome (Q50670959)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 February 2016

Language	Label	Description	Also known as
English	Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome	scientific article published on 11 February 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/26866723

Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/26866723

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Naomi I Maria

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Cornelia G van Helden-Meeuwsen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Sandra M J Paulissen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Eline C Steenwijk

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Virgil A Dalm

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Paul L van Daele

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

P Martin van Hagen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Frans G M Kroese

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Joel A G van Roon

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Andrew Harkin

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Willem A Dik

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Hemmo A Drexhage

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Erik Lubberts

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Marjan A Versnel

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

publication date

11 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/26866723

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

1688-1699

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26866723 AND SRC:MED&resulttype=core&format=json

12 June 2020

Primary Sjogren syndrome: clinical and immunopathologic features

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Peripheral blood gene expression profiling in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

On watching the watchers: IDO and type I/II IFN

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Kynurenines in the mammalian brain: when physiology meets pathology

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Role of kynurenines in the central and peripheral nervous systems

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

The kynurenine system and immunoregulation

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Kynurenines in CNS disease: regulation by inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

IDO expands human CD4 CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Tolerance, DCs and tryptophan: much ado about IDO

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Phenotypical and functional specialization of FOXP3 regulatory T cells

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Interferon-α suppresses cAMP to disarm human regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Indoleamine 2,3-dioxygenase: from catalyst to signaling function

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

IL-17/Th17 mediated synovial inflammation is IL-22 independent

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

IL-7 abrogates suppressive activity of human CD4 CD25 FOXP3 regulatory T cells and allows expansion of alloreactive and autoreactive T cells

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Kynurenines in the CNS: recent advances and new questions.

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate

1 reference

https://api.crossref.org/works/10.1002/ART.39629

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50670959&oldid=2256630095"